Hormone Replacement Therapy Market is estimated to be US$ 14.7 Billion by 2030 with a CAGR of 7.50% during the forecast period

 


Hormone replacement therapy market accounted for US$ 7.16 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 7.50%. Hormone replacement therapy (HRT), also known as menopausal hormone therapy or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause.These symptoms can include hot flashes, vaginal atrophy, accelerated skin aging, vaginal dryness, decreased muscle mass, sexual dysfunction, and bone loss. They are in large part related to the diminished levels of sex hormones that occur during menopause. The main hormonal medications used in HRT for menopausal symptoms are estrogens and progestogens, among which progesterone is the major naturally-occurring female sex hormone and also a manufactured medication used in menopausal hormone therapy. Though both can have symptomatic benefits, progestogen is specifically added to estrogen regimens when the uterus is still present. Unopposed estrogen therapy promotes endometrial thickening and can increase the risk of cancer, while progestogen reduces this risk. Androgens like testosterone are sometimes used as well. HRT is available through a variety of different routes.

The report " Global Hormone Replacement Therapy Market, By Therapy Type (Human Growth Hormone (HGH) Replacement Therapy, Testosterone Replacement Therapy, Thyroid Replacement Therapy, Estrogen Replacement Therapy), By Application (Growth Hormone Deficiency, Menopause, Hypothyroidism, Male Hypogonadism, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa ) - Trends, Analysis and Forecast till 2030”

Key Highlights:

·         In December 2020, US FDA approved the Myovant Sciences' Orgovyx (relugolix), which is an orally administered treatment that works by blocking the pituitary from making hormones called LH and FSH, thus resulting in the reduction within the amount of testosterone produced by the testicles. Thus, aiding within the treatment of adult patients with advanced prostatic adenocarcinoma.

·         In August 2020, Bayer AG announced the acquisition of KanDy Therapeutics, Inc, which aids within the expansion of Bayer's women's drug pipeline by adding KanDy's menopause drug thereto portfolio.

Analyst View:

High prevalence of hormone related disorder is expected to drastically increase the demand for hormone replacement therapy market in near future. As per estimated of American Thyroid Association (ATA), More than 12 percent of the U.S. population will develop a thyroid condition during their lifetime and around 20 million Americans have some form of thyroid disease.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

 

Key Market Insights from the report:

The global hormone replacement therapy market accounted for US$ 7.16 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 7.50%. The global hormone replacement therapy market has been segmented on the basis of therapy type, application, route of administration, distribution channel and region.

·         By Therapy Type, the market is segmented into human growth hormone (HGH) replacement therapy, testosterone replacement therapy, thyroid replacement therapy, and estrogen replacement therapy.

·         By Application, the market is segmented into growth hormone deficiency, menopause, hypothyroidism, male hypogonadism, and others.

·         By Route of Administration, the Global Hormone Replacement Therapy Market is segmented into oral, parenteral, and others.

·         By Distribution Channel, the Global Hormone Replacement Therapy Market is segmented into hospital, retail pharmacies, and online pharmacies.

·          By Region, the Global Hormone Replacement Therapy Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region is expected to be the largest hormone replacement therapy market.

Competitive Landscape:

The Key players operating in the global Hormone replacement therapy market includes, Merck KgaA, Abbott Laboratories, Eli Lilly and Company, Novartis International AG, Pfizer Inc., Bayer AG, QuatRx Pharmaceuticals, Mylan N.V., Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Novo Nordisk A/S.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

·         Explains an overview of the product portfolio, including product development, planning, and positioning.

·         Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.

·         Detailed analysis of the market revenue over the forecasted period.

·         Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.

·         Study on the segments that are anticipated to dominate the market.

·         Study on the regional analysis that is expected to register the highest growth over the forecast period.

Key Topics Covered

1.       Introduction

·         Study Deliverables

·         Study Assumptions

·         Scope of the Study

2.       Research Methodology

3.       Executive Summary

·         Opportunity Map Analysis

·         Market at Glance

·         Market Share (%) and BPS Analysis, by Region

·         Competitive Landscape

·         Heat Map Analysis 

·         Market Presence and Specificity Analysis

4.       Investment Analysis

5.       Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Antibody Drug Conjugate Market is estimated to be US$ 27.0 billion by 2030 with a CAGR of 23.5% during the forecast period

Image
  Antibody drug conjugate market accounted for US$ 3.3 billion in 2020 and is estimated to be US$ 27.0 billion by 2030 and is anticipated to register a CAGR of 23.5% . Antibody-drug conjugates or ADCs are biopharmaceutical drugs designed for targeted therapy for treating various type of cancer. ADCs are expose to target and kill tumor cells while sparing healthy cells. As of now 59npharmaceutical companies developed ADCs. These are complex molecules composed of antibody and have capability to target cancer cells by discriminating healthy tissues and diseased tissues. The report "   Global Antibody Drug Conjugate Market, By Technology (Cleavable Linker and Non-Cleavable Linker), By Application (Blood Cancer, Ovarian Cancer, Lung Cancer and Brain Tumor), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”...
Read more

Inulin Market is estimated to be US$ 2.29 billion by 2030 with a CAGR of 5.5% during the forecast period

Image
  The report "Global Inulin Market , By Application (Food and Beverage, Dietary Supplements, and Pharmaceutical) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”. Increasing awareness about prebiotic ingredients and their extensive utilization in food and beverages industry is the major factor driving the growth of the global inulin market globally. Inulin has various applications in dairy product formation such as cheese, yogurts, and ice-cream. Hence, the growth in dairy industries is projected to boost additional growth in inulin market over the forecast period. Also, high growth in the pharmaceuticals industry worldwide is propelling the growth of the target market. Furthermore, the fast-growing significance of nutraceuticals due to increasing health awareness is expected to increase demand for inulin as a functional ingredient. Key Highlights: In June 2018, Cosucra’s inulin-type fru...
Read more

Intraocular Lens Market is estimated to be US$ 7.9 billion by 2032 with a CAGR of 7.2% over the forecast period (2022-2032)

Image
  The Intraocular Lenses implant is routinely utilized during cataract surgery. Intraocular Lenses work as natural lenses. Lens implant has various focusing powers like prescription contact lenses or eyeglasses. There are different types of Intraocular Lenses like – Monofocal IOLs, which has one focal point & can be set to focus on close, medium, and distance vision which is based on preference. Distance vision is the most common selection. Trifocal IOLs, help to see better in distance, computer distance, and reading distance. Trifocal IOLs help in allowing to see both the distance and near while looking in any kind of direction. Toric IOLs is used if one has significant eye astigmatism. Astigmatism result when cornea flatter in one direction like a football. Toric Intraocular Lenses are designed for correcting astigmatism and allows to have great vision without glasses. Phakic lenses are commonly used for correcting moderate to severe nearsightedness. Phakic lenses are surgic...
Read more